Novavax begins phase 2 COVID-19 vaccine trials in South Africa

American vaccine group Novavax has begun its phase 2 clinical trials in South Africa this week, this trial is supported in part by a $15 million grant from the Bill & Melinda Gates Foundation and will be led by Dr. Shabir Madhi, Professor of Vaccinology at Wits University. Dr. Shabir Madhi joins CNBC Africa for more.

Wed Aug 19 2020 | 11:45:29 GMT+0000 (Coordinated Universal Time)


Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent. Sign up here.